2023年

英文

1. Schüz J, Ostroumova E, Kesminiene A, Davies L, Ahn HS, Togawa K, Vaccarella S. Response to Toshihide Tsuda, Yumiko Miyano and Eiji Yamamoto. Environ Health. 2023 Jan 26;22(1):13.[PubMed]
2. Tanaka H, Mackenbach JP, Kobayashi Y. Estimation of socioeconomic inequalities in mortality in Japan using national census-linked longitudinal mortality data. J Epidemiol. 2023;33(5):246-255.[PubMed]
3. Tanaka H, Tanaka S, Togawa K, Katanoda K. Practical implications of the update to the 2015 Japan Standard Population: mortality archive from 1950 to 2020 in Japan. J Epidemiol.2023;33(7):372-380.[PubMed]
   【研究内容の紹介】→ [詳細はこちら]
4. Mitsutake S, Takahashi Y, Otsuki A, et al. Chronic Diseases and Sociodemographic Characteristics Associated With Online Health Information Seeking and Using Social Networking Sites: Nationally Representative Cross-sectional Survey in Japan. J Med Internet Res. 2023;25:e44741. Published 2023 Mar 2. [PubMed]
   
5. Goto A, Katanoda K. Should We Acknowledge ChatGPT as an Author?. J Epidemiol. 2023;33(7):333-334.[PubMed]
6. Minami T, Inoue M, Tabuchi T, Katanoda K. Voluntary suspension of medically-assisted reproduction during the COVID-19 pandemic in Japan: a nationwide internet survey. Hum Fertil (Camb). 2023;26(1):169-181.[PubMed]
7. Charvat H, Fukui K, Matsuda T, Katanoda K, Ito Y. Impact of cancer and other causes of death on mortality of cancer patients: A study based on Japanese population-based registry data. Int J Cancer. 2023;153(6):1162-1171.[PubMed]
8. Katanoda K, Tanaka H, Tanaka S, Togawa K. Toward Better Utilization of the 2015 Japan Standard Population. J Epidemiol. 2023;33(10):545.[PubMed]
9. Sugiyama T, Yanagisawa-Sugita A, Tanaka H, et al. Different incidences of diabetic retinopathy requiring treatment since diagnosis according to the course of diabetes diagnosis: a retrospective cohort study. Sci Rep. 2023;13(1):10527. Published 2023 Jun 29.[PubMed]
10. Nakata K, Matsuda T, Hori M, Sugiyama H, Tabuchi K, Miyashiro I, Matsumoto K, Yoneda A, Takita J, Shimizu C, Katanoda K. Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016-2018. Cancer Sci. 2023;114(9):3770-3782.[PubMed]
11. Usui Y, Ito H, Katanoda K, Matsuda T, Maeda Y, Matsuo K. Trends in non-Hodgkin lymphoma mortality rate in Japan and the United States: A population-based study. Cancer Sci. 2023;114(10):4073-4080.[PubMed]
12. Tanaka H, Togawa K, Katanoda K. Impact of the COVID-19 pandemic on mortality trends in Japan: a reversal in 2021? A descriptive analysis of national mortality data, 1995-2021. BMJ Open. 2023;13(8):e071785. Published 2023 Aug 31.[PubMed]
    【研究内容の紹介】→ [詳細はこちら（研究トピックス）]
13. Saito E, Tanaka S, Abe SK, Hirayabashi M, Ishihara J, Katanoda K, Lin Y, Nagata C, Sawada N, Takachi R, Goto A, Tanaka J, Ueda K, Hori M, Matsuda T, Inoue M. Economic burden of cancer attributable to modifiable risk factors in Japan. Glob Health Med. 2023 Aug 31;5(4):238-245.[PubMed]
14. Palmer M, Katanoda K, Saito E, Acuti Martellucci C, Tanaka S, Ikeda S, Sakamoto H, Machalek D, Brotherton JML, Hocking JS. Corrigendum to "Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis" [Vaccine 40(41) (2022) 5971-5996]. Vaccine. 2023 Sep 1:S0264-410X(23)00787-9.[PubMed]
15. Funada S, Yoshioka T, Luo Y, Iwama T, Mori C, Yamada N, Yoshida H, Katanoda K, Furukawa TA. Global Trends in Highly Cited Studies in COVID-19 Research. JAMA Netw Open. 2023 Sep 5;6(9):e2332802.[PubMed]
16. Nguyen PT, Hori M, Matsuda T, Katanoda K. Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020-2050: A Statistical Modeling Study. Cancer Epidemiol Biomarkers Prev. 2023 Dec 1;32(12):1756-1770.[PubMed]
17. Ong SK, Abe SK, Thilagaratnam S, Togawa K et al. Towards elimination of cervical cancer - human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries. Lancet Reg Health West Pac. 2023 Aug 1;39:100860.[PubMed]
18. Kim J, Leon ME, Schinasi LH, Togawa K et al. Exposure to pesticides and risk of Hodgkin lymphoma in an international consortium of agricultural cohorts (AGRICOH). Cancer Causes Control. 2023;34(11):995-1003.[PubMed]
19. Boucheron P, Zietsman A, Pontac J, Hansen R, Anderson BO, Togawa K, Macharia PM, Foerster M, Schüz J, Dos-Santos-Silva I, McCormack V. Analysis of the Breast Cancer Journey in Namibia. JAMA Netw Open. 2023 Nov 1;6(11):e2341402.[PubMed]

和文

1. 田中宏和, 田淵貴大, 片野田耕太. 新型コロナウイルスワクチン接種状況と接種証明書の活用に関する意識：2021年9-10月の調査（JACSIS研究）. 日本公衆衛生雑誌. 2023;70(3):171-184, 2023
2. 片野田 耕太, 伊藤 秀美, 伊藤 ゆり, 片山 佳代子, 西野 善一, 筒井 杏奈, 十川 佳代, 田中 宏和, 大野 ゆう子, 中谷 友樹.諸外国でのがん登録データの地理情報の利用事例とわが国の全国がん登録の諸問題：日本公衆衛生雑誌 70(3):163-170, 2023
   
3. 柘植 博之, 川北 大介, 谷山 ゆかり, 小柳 友理子, 尾瀬 功, 片野田 耕太, 伊藤 ゆり, 松田 智大, 岩崎 真一, 伊藤 秀美.地域がん登録データより求めた,頭頸部がん長期生存率の経年変化 :頭頸部癌 49(2) 171-171,202
4. 田中 宏和, 片野田 耕太. 【胆道癌と膵癌のリスクファクター】喫煙と発がん：胆と膵 44(9) 807-813, 2023